Leaflet OMNISCAN 287mg / ml solution for injection
Indicated for: diagnostic imaging contrast enhancement
Route of administration: injectable
Substance: gadodiamide (contrast agent)
ATC: V08CA03 (Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
This medicine may affect the kidneys.
Gadodiamide is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to improve the visibility of organs and blood vessels. This medication helps obtain detailed images, making it easier to diagnose conditions such as tumors, inflammation, or central nervous system lesions.
Gadodiamide is administered intravenously, usually before or during the MRI procedure. The dose is determined by the doctor based on the patient's weight and general condition. The procedure is quick and generally well tolerated by most patients.
Side effects may include a sensation of warmth, metallic taste, nausea, or reactions at the injection site. In rare cases, severe allergic reactions or impaired kidney function may occur, especially in patients with pre-existing kidney disease. It is important to inform your doctor about any conditions or allergies before the examination.
Gadodiamide is an effective contrast agent for MRI, but its use requires careful medical supervision. Follow your doctor's instructions and report any unusual symptoms after the examination to prevent complications.
General data about OMNISCAN 287mg / ml
- Substance: gadodiamide
- Date of latest medicines list: 01-07-2014
- Product code: W12009006
- Concentration: 287mg / ml
- Pharmaceutical form: solution for injection
- Quantity: 10
- Product type: Original
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Concentrations available for gadodiamide
- 0.5mmol/ml
- 287mg/ml